Session

IBD (Posters)

INCIDENCE AND RISK FACTORS ASSOCIATED WITH RECURRENCE OF CROHN_S DISEASE AFTER DEFINITIVE PANPROCTOCOLECTOMY AND ILEOSTOMY: THE IFARPI STUDY
INCIDENCE AND RISK FACTORS ASSOCIATED WITH RECURRENCE OF CROHN_S DISEASE AFTER DEFINITIVE PANPROCTOCOLECTOMY AND ILEOSTOMY: THE IFARPI STUDY

USE OF GASTRIC ACID SUPPRESSANTS AND RISK OF DISEASE ACTIVITY EXACERBATION IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
USE OF GASTRIC ACID SUPPRESSANTS AND RISK OF DISEASE ACTIVITY EXACERBATION IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

PREGNANCY COMPLICATIONS IN WOMEN WITH INFLAMMATORY BOWEL DISEASE: A NATIONAL COHORT STUDY
PREGNANCY COMPLICATIONS IN WOMEN WITH INFLAMMATORY BOWEL DISEASE: A NATIONAL COHORT STUDY

VITAMIN D AND BONE MINERAL DISEASE IN INFLAMMATORY BOWEL DISEASE PATIENTS
VITAMIN D AND BONE MINERAL DISEASE IN INFLAMMATORY BOWEL DISEASE PATIENTS

IMPACT ON QUALITY OF LIFE OF SETON PLACING IN PERIANAL CROHN'S DISEASE
IMPACT ON QUALITY OF LIFE OF SETON PLACING IN PERIANAL CROHN'S DISEASE

ASSESSMENT OF THE NUTRITIONAL STATUS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO DISEASE ACTIVITY
ASSESSMENT OF THE NUTRITIONAL STATUS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO DISEASE ACTIVITY

MACROPHAGES AS AN EMERGING SOURCE OF NOTCH LIGANDS: RELEVANCE IN CROHN_S DISEASE COMPLICATIONS
MACROPHAGES AS AN EMERGING SOURCE OF NOTCH LIGANDS: RELEVANCE IN CROHN_S DISEASE COMPLICATIONS

MANAGEMENT OF PATIENTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BASED ON HOSPITAL CHARACTERISTICS: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU
MANAGEMENT OF PATIENTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BASED ON HOSPITAL CHARACTERISTICS: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY
USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY

PREVALENCE OF ANTI-ANISAKIS SIMPLEX ANTIBODIES IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN NORWAY: CORRELATION WITH DISEASE PHENOTYPE AND CLINICAL ACTIVITY
PREVALENCE OF ANTI-ANISAKIS SIMPLEX ANTIBODIES IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN NORWAY: CORRELATION WITH DISEASE PHENOTYPE AND CLINICAL ACTIVITY

TOFACITINIB IN SEVERE STEROID RESISTANT ULCERATIVE COLITIS AS A RESCUE THERAPY
TOFACITINIB IN SEVERE STEROID RESISTANT ULCERATIVE COLITIS AS A RESCUE THERAPY

EARLY BIOMARKERS OF RESPONSE TO FERRIC CARBOXYMALTOSE TREATMENT IN GASTROINTESTINAL-RELATED INFLAMMATORY AND NON-INFLAMMATORY IRON DEFICIENCY ANEMIA: A PRELIMINARY STUDY
EARLY BIOMARKERS OF RESPONSE TO FERRIC CARBOXYMALTOSE TREATMENT IN GASTROINTESTINAL-RELATED INFLAMMATORY AND NON-INFLAMMATORY IRON DEFICIENCY ANEMIA: A PRELIMINARY STUDY

PATIENTS WITH CROHN'S DISEASE HAVE MORE PSYCHOPATHOLOGY THAN THE NORMATIVE POPULATION, BUT LESS THAN PSYCHIATRIC OUTPATIENTS
PATIENTS WITH CROHN'S DISEASE HAVE MORE PSYCHOPATHOLOGY THAN THE NORMATIVE POPULATION, BUT LESS THAN PSYCHIATRIC OUTPATIENTS

CONTINUATION OF ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSION IS NOT COST-EFFECTIVE COMPARED TO TREATMENT WITHDRAWAL: A MARKOV MODEL
CONTINUATION OF ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSION IS NOT COST-EFFECTIVE COMPARED TO TREATMENT WITHDRAWAL: A MARKOV MODEL

IDENTIFICATION OF RELEVANT PATIENT REPORTED OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - LISTEN I
IDENTIFICATION OF RELEVANT PATIENT REPORTED OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - LISTEN I

VACCINES AND IMMUNIZATION STATUS IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE. EVALUATION AT DIAGNOSIS
VACCINES AND IMMUNIZATION STATUS IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE. EVALUATION AT DIAGNOSIS

PREDICTING TOFACITINIB INDUCED ENDOSCOPIC RESPONSE IN ULCERATIVE COLITIS THROUGH A MUCOSAL BIOMARKER
PREDICTING TOFACITINIB INDUCED ENDOSCOPIC RESPONSE IN ULCERATIVE COLITIS THROUGH A MUCOSAL BIOMARKER

ENDOSCOPIC AND HISTOLOGIC REMISSION IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT
ENDOSCOPIC AND HISTOLOGIC REMISSION IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT

EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN_S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN_S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

SHORT DISEASE DURATION AND SUPERFICIAL PENETRATION WITHIN THE ILEAL WALL ARE ASSOCIATED TO M1 MACROPHAGES INFILTRATION AND ACTIVATION IN ILEOCOLONIC CROHN_S DISEASE
SHORT DISEASE DURATION AND SUPERFICIAL PENETRATION WITHIN THE ILEAL WALL ARE ASSOCIATED TO M1 MACROPHAGES INFILTRATION AND ACTIVATION IN ILEOCOLONIC CROHN_S DISEASE

Item 1 - 20 / 558
1
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28